Ana Vallejo, Author at Myeloma Patients Europe - Page 2 of 15

EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE

Ana Vallejo

test

Watch the recording of the EHA 2023 highlights webinar

AL amyloidosis, MPE, Myeloma, VideosJuly 10, 2023

Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern Europe

Access, MyelomaJune 25, 2023

EHA 2023 highlights in myeloma and AL amyloidosis

AL amyloidosis, Conferences, Myeloma, VideosJune 14, 2023

Job Offer – Access and Policy Project Manager

MPEJune 6, 2023

Myeloma Patients Europe appoints joint CEOs

MPEMarch 27, 2023

Job offer – Medical and Scientific officer

MPEMarch 1, 2023

Daratumumab approved for first line treatment in Israel

MPE, MyelomaJanuary 30, 2023

Study shows the importance of vaccination for myeloma patients

MyelomaJanuary 26, 2023

Access to generic lenalidomide (e.g. Revlimid) in Europe

Access, MyelomaFebruary 28, 2022

MPE Publishes 2021: Year in Review

MPEFebruary 9, 2022